Sentinel lymph node mapping in esophageal and gastric cancer.

Yuukou Kitagawa, Hirofumi Fujii, Makio Mukai, Atsushi Kubo, Masaki Kitajima

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

In recent years, the sentinel lymph node (SLN) concept has been widely investigated in a variety of solid tumors including gastrointestinal (GI) cancer. This chapter reviews the rationale and refined technical aspects for SLN mapping in upper GI cancer for the intraoperative accurate diagnosis of nodal status to perform individualized minimally invasive surgical approaches. We have described the technical details of the procedure as we have performed it in over 350 consecutive patients with esophageal and gastric cancer and introduced pitfalls and issues remaining. The technical details and clinical applications of SLN mapping differfor patients with esophageal cancer and gastric cancer. Radio-guided method with lymphoscintigraphy using radioisotope-labeled colloid (RI) is essential for SLN mapping for esophageal cancer. Selective lymphadenectomy and SLN-targeted chemoradiotherapy would be feasible and beneficial for the patients with esophageal cancer. For gastric cancer, combined method with dye and RI is recommended for stable and accurate sampling of SLN in the laparoscopic setting. Laparoscopic local resection for superficial gastric cancer with negative SN status would be a reasonable and less-invasive novel procedure based on the SLN concept. We can utilize this procedure not only for an accurate staging but also as a great tool to change the patient care of upper GI cancer by individualized minimally invasive treatments.

Original languageEnglish
Pages (from-to)123-139
Number of pages17
JournalCancer Treatment and Research
Volume127
Publication statusPublished - 2005

Fingerprint

Esophageal Neoplasms
Stomach Neoplasms
Gastrointestinal Neoplasms
Lymphoscintigraphy
Colloids
Chemoradiotherapy
Sentinel Lymph Node
Lymph Node Excision
Radio
Radioisotopes
Patient Care
Coloring Agents
Neoplasms

Cite this

Kitagawa, Y., Fujii, H., Mukai, M., Kubo, A., & Kitajima, M. (2005). Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treatment and Research, 127, 123-139.

Sentinel lymph node mapping in esophageal and gastric cancer. / Kitagawa, Yuukou; Fujii, Hirofumi; Mukai, Makio; Kubo, Atsushi; Kitajima, Masaki.

In: Cancer Treatment and Research, Vol. 127, 2005, p. 123-139.

Research output: Contribution to journalArticle

Kitagawa, Y, Fujii, H, Mukai, M, Kubo, A & Kitajima, M 2005, 'Sentinel lymph node mapping in esophageal and gastric cancer.', Cancer Treatment and Research, vol. 127, pp. 123-139.
Kitagawa, Yuukou ; Fujii, Hirofumi ; Mukai, Makio ; Kubo, Atsushi ; Kitajima, Masaki. / Sentinel lymph node mapping in esophageal and gastric cancer. In: Cancer Treatment and Research. 2005 ; Vol. 127. pp. 123-139.
@article{e060e39fbe5d4b3ca98b8659e24d9179,
title = "Sentinel lymph node mapping in esophageal and gastric cancer.",
abstract = "In recent years, the sentinel lymph node (SLN) concept has been widely investigated in a variety of solid tumors including gastrointestinal (GI) cancer. This chapter reviews the rationale and refined technical aspects for SLN mapping in upper GI cancer for the intraoperative accurate diagnosis of nodal status to perform individualized minimally invasive surgical approaches. We have described the technical details of the procedure as we have performed it in over 350 consecutive patients with esophageal and gastric cancer and introduced pitfalls and issues remaining. The technical details and clinical applications of SLN mapping differfor patients with esophageal cancer and gastric cancer. Radio-guided method with lymphoscintigraphy using radioisotope-labeled colloid (RI) is essential for SLN mapping for esophageal cancer. Selective lymphadenectomy and SLN-targeted chemoradiotherapy would be feasible and beneficial for the patients with esophageal cancer. For gastric cancer, combined method with dye and RI is recommended for stable and accurate sampling of SLN in the laparoscopic setting. Laparoscopic local resection for superficial gastric cancer with negative SN status would be a reasonable and less-invasive novel procedure based on the SLN concept. We can utilize this procedure not only for an accurate staging but also as a great tool to change the patient care of upper GI cancer by individualized minimally invasive treatments.",
author = "Yuukou Kitagawa and Hirofumi Fujii and Makio Mukai and Atsushi Kubo and Masaki Kitajima",
year = "2005",
language = "English",
volume = "127",
pages = "123--139",
journal = "Cancer Treatment and Research",
issn = "0927-3042",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Sentinel lymph node mapping in esophageal and gastric cancer.

AU - Kitagawa, Yuukou

AU - Fujii, Hirofumi

AU - Mukai, Makio

AU - Kubo, Atsushi

AU - Kitajima, Masaki

PY - 2005

Y1 - 2005

N2 - In recent years, the sentinel lymph node (SLN) concept has been widely investigated in a variety of solid tumors including gastrointestinal (GI) cancer. This chapter reviews the rationale and refined technical aspects for SLN mapping in upper GI cancer for the intraoperative accurate diagnosis of nodal status to perform individualized minimally invasive surgical approaches. We have described the technical details of the procedure as we have performed it in over 350 consecutive patients with esophageal and gastric cancer and introduced pitfalls and issues remaining. The technical details and clinical applications of SLN mapping differfor patients with esophageal cancer and gastric cancer. Radio-guided method with lymphoscintigraphy using radioisotope-labeled colloid (RI) is essential for SLN mapping for esophageal cancer. Selective lymphadenectomy and SLN-targeted chemoradiotherapy would be feasible and beneficial for the patients with esophageal cancer. For gastric cancer, combined method with dye and RI is recommended for stable and accurate sampling of SLN in the laparoscopic setting. Laparoscopic local resection for superficial gastric cancer with negative SN status would be a reasonable and less-invasive novel procedure based on the SLN concept. We can utilize this procedure not only for an accurate staging but also as a great tool to change the patient care of upper GI cancer by individualized minimally invasive treatments.

AB - In recent years, the sentinel lymph node (SLN) concept has been widely investigated in a variety of solid tumors including gastrointestinal (GI) cancer. This chapter reviews the rationale and refined technical aspects for SLN mapping in upper GI cancer for the intraoperative accurate diagnosis of nodal status to perform individualized minimally invasive surgical approaches. We have described the technical details of the procedure as we have performed it in over 350 consecutive patients with esophageal and gastric cancer and introduced pitfalls and issues remaining. The technical details and clinical applications of SLN mapping differfor patients with esophageal cancer and gastric cancer. Radio-guided method with lymphoscintigraphy using radioisotope-labeled colloid (RI) is essential for SLN mapping for esophageal cancer. Selective lymphadenectomy and SLN-targeted chemoradiotherapy would be feasible and beneficial for the patients with esophageal cancer. For gastric cancer, combined method with dye and RI is recommended for stable and accurate sampling of SLN in the laparoscopic setting. Laparoscopic local resection for superficial gastric cancer with negative SN status would be a reasonable and less-invasive novel procedure based on the SLN concept. We can utilize this procedure not only for an accurate staging but also as a great tool to change the patient care of upper GI cancer by individualized minimally invasive treatments.

UR - http://www.scopus.com/inward/record.url?scp=27244452293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27244452293&partnerID=8YFLogxK

M3 - Article

C2 - 16209080

AN - SCOPUS:27244452293

VL - 127

SP - 123

EP - 139

JO - Cancer Treatment and Research

JF - Cancer Treatment and Research

SN - 0927-3042

ER -